Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 9—September 2002

A Case-Case Comparison of Campylobacter coli and Campylobacter jejuni Infection: A Tool for Generating Hypotheses

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Iain Gillespie*, Sarah J. O’Brien*Comments to Author , Jennifer A. Frost†, Goutam K. Adak*, Le Hong Phong*, Anthony V. Swan‡, Michael J. Painter§, Keith R. Neal¶, and the Campylobacter Sentinel Surveillance System Collaborators 1
Author affiliations: *Public Health Laboratory Service (PHLS) Communicable Disease Surveillance Centre, London, United Kingdom; †PHLS Laboratory of Enteric Pathogens, London, United Kingdom; ‡PHLS Statistics Unit, London, United Kingdom; §Manchester Health Authority, Manchester, United Kingdom; ¶University of Nottingham, Nottingham, United Kingdom;

Cite This Article


Preventing campylobacteriosis depends on a thorough understanding of its epidemiology. We used case-case analysis to compare cases of Campylobacter coli infection with cases of C. jejuni infection, to generate hypotheses for infection from standardized, population-based sentinel surveillance information in England and Wales. Persons with C. coli infection were more likely to have drunk bottled water than were those with C. jejuni infection and, in general, were more likely to have eaten pâté. Important differences in exposures were identified for these two Campylobacter species. Exposures that are a risk for infection for both comparison groups might not be identified or might be underestimated by case-case analysis. Similarly, the magnitude or direction of population risk cannot be assessed accurately. Nevertheless, our findings suggest that case-control studies should be conducted at the species level.

Campylobacters are the most commonly reported bacterial cause of acute gastroenteritis in the industrialized world (1). In the United Kingdom (UK), laboratory reports of campylobacter have increased steadily since surveillance began in 1977; in 1999, >60,000 cases were reported (incidence rate 103.7 per 100,000). However, the true population burden of campylobacter infection is thought to be much higher. For every laboratory-confirmed case reported to national surveillance in England, an additional eight cases may be unrecognized (2). This estimate suggests that in 1999, approximately half a million people in the UK became ill with campylobacter enteritis. The cost to the nation of a case of campylobacter infection has been estimated as £314.00 (at 1994–95 prices) (3); in 1999 campylobacter infection probably cost the nation >£150 million (US$ 225 million). The clinical complications of campylobacter infection include toxic megacolon, hemolytic uremic syndrome, Reiter’s syndrome, and Guillain Barré syndrome, the most common cause of acute neuromuscular paralysis in the industrialized world (4).

Although campylobacters were recognized as important pathogens >20 years ago, their epidemiology is still poorly understood (58). Eating poultry has long been a leading hypothesis for spread of campylobacter infection, but few case-control studies have identified it as a major risk factor except in a commercial context (911). An estimated 20% to 40% of sporadic disease might result from eating chicken (12,13). Although a variety of food vehicles and other risk factors have been reported in several case-control studies, most cases in these studies remain unexplained by the risk factors identified (511).

Figure 1

Thumbnail of The health authorities in England and Wales participating in the sentinel surveillance scheme for Campylobacter.

Figure 1. The health authorities in England and Wales participating in the sentinel surveillance scheme for Campylobacter.

A difficulty, until recently, has been the lack of routine microbiologic characterization of clinical strains (14), which has militated against systematic study of the epidemiology of the different species and subtypes of campylobacter. Control and prevention strategies cannot be developed and implemented without proper understanding of the epidemiology of campylobacter infection. On May 1, 2000, an active, population-based sentinel surveillance scheme for campylobacter infections was initiated in England and Wales (15). Its aim is to generate hypotheses for human campylobacter infection by using a systematic, integrated epidemiologic and microbiologic approach. Twenty-two district health authorities are collaborating in the scheme, working with their hospital microbiology and local environmental health departments (Figure 1). The sentinel system covers a population of approximately 12.5 million and captures standardized information on approximately 15% of all laboratory-confirmed campylobacter infections in England and Wales. The health authorities are broadly representative of England and Wales as a whole.

We have used case-case comparisons, an adaptation of conventional case-control methods, as suggested by McCarthy and Giesecke (16), to generate hypotheses concerning risk factors for campylobacter infection. We report results from the first year of the study and discuss the strengths and weaknesses of case-case analysis.


Campylobacters isolated by National Health Service and Public Health Laboratory Service (PHLS) laboratories within the catchment area were referred to the Campylobacter Reference Unit of the PHLS Laboratory of Enteric Pathogens for speciation, serotyping, phage typing, and antibiotic resistance testing (1720). A standard, structured clinical and exposure questionnaire was administered to each patient by the health or local authority as part of the routine investigation of foodborne infection. The questionnaire, which can be completed by the patient, captured demographic and clinical data, as well as travel history (foreign and domestic), food history (>20 exposures), milk (3 exposures) and water (8 exposures) consumption, recreational water activity, animal contacts, and other illness (either in the household or the community) during the 2 weeks before the onset of illness. Epidemiologic exposure data and microbiologic typing information were then collated centrally by the Gastrointestinal Diseases Division of the PHLS Communicable Disease Surveillance Centre.

The combined epidemiologic and microbiologic dataset, generated through the sentinel scheme, was analyzed by Stata version seven (Stata Corporation, College Station, TX). For the case-case analysis, illness in patients infected with C. coli was designated a “case;” patients infected with C. jejuni were designated as controls. Differences in demographic and clinical data were assessed by using Pearson’s chi-square test and the Student t test. Cases were excluded from analysis if a patient was infected with more than one campylobacter subtype (133 cases) or was confirmed as infected with C. lari (two patients) or C. fetus (one patient).

The date of onset of illness for cases was used to define the month of onset and approximations of the four seasons (spring, March–May; summer, June–August; autumn, September–November; winter, December–February) were calculated. Socioeconomic group, based on occupation, was determined by standard occupational classification (21). Additional categories were generated for persons who described their occupation as unemployed, preschool child, school child, student, homemaker, retired, or part time, and for those who were unable to work because of disabilities or long-term illness. Food exposures were coded to compare those who had eaten a particular food in the 2 weeks before onset of illness (once or more than once) with those who had not. Daily water consumption was coded to differentiate no exposure from 1–4, 5–9, and >10 glasses of water drunk. Patient age was classified in 10-year age groups. Persons with missing data were omitted from the analyses using those data.

Initially, comparisons between C. coli and C. jejuni cases were performed by single-risk variable analyses. Mantel-Haenszel odds ratios (OR) were calculated for each explanatory variable. Logistic regression was applied to obtain maximum likelihood estimates of the effect of exposures on the species-specific outcome, while the data were controlled for potential confounders. Variables with a p value <0.1 from the single-risk variable analysis were included initially. Stepwise exclusion was used to simplify the model: variables were removed one at a time and tested for significance by the likelihood ratio (LR) test. Potential interactions (among the main effects included in the initial logistic regression model were age, sex, and season) were also examined by using the LR chi-square test.


Figure 2

Thumbnail of Age distribution of Campylobacter coli and C. jejuni cases reported to the sentinel surveillance scheme.

Figure 2. Age distribution of Campylobacter coli and C. jejuni cases reported to the sentinel surveillance scheme.

Epidemiologic data have been gathered for 7,360 laboratory-confirmed cases of campylobacter infection during the first year of the study (response rate 7,360 [76%] of 9,655). The median delay between onset of symptoms and completion of a questionnaire was 16 days. Case-patients ranged from <1 month to 99 years of age (Figure 2), and the overall sex distribution was even. Diarrhea (95%), abdominal pain (85%), and fever (78%) were the most commonly reported symptoms, with vomiting (35%) and bloody diarrhea (27%) reported less frequently. A total of 6,948 case-patients amassed 79,090 days of illness (mean 11), and 10% were hospitalized for an average of 5 days (range 1–42 days). Six hundred fifty-nine patients accumulated 3,048 hospital days. Five thousand one hundred seven patients reported absence from work or an inability to undertake normal activities for a total of 38,769 days (mean 8 days).

Linked epidemiologic and microbiologic data are available for 3,764 cases. C. jejuni accounted for 3,489 (93%) of the cases, with 272 C. coli (7%), 2 C. lari (<1%), and 1 C. fetus (<1%) also reported. Case-patients with C. coli and C. jejuni infection did not differ with regard to sex, clinical symptoms, or duration of illness (Table 1). However, case-patients infected with C. coli tended to be older (mean 42.9 years) than patients with C. jejuni (mean 38.5 years) (p=0.001).

Patients with C. coli infection were more likely to describe their ethnicity as Asian and to have traveled abroad in the 2 weeks before the onset of symptoms (single-risk variable analysis; Table 2). Patients with C. coli were also more likely to report having eaten specific types of meats (Halal meat [meat slaughtered according to Islamic law], meat pies, offal [organ meats], and pâté) and bottled water. They were less likely to have had contact with animals than were patients with C. jejuni infection. Persons with C. coli and those with C. jejuni infection did not differ with regard to eating chicken (89.8% vs. 90.8%; odds ratio [OR] 0.89; 95% confidence interval [CI] 0.58 to 1.36; chi square 0.59) or other types of poultry (23.6% vs. 19.7%; OR 1.26; 95% CI 0.91 to 1.74; chi square 0.16) in the 2 weeks before onset of illness.

Patients with C. coli infection were more likely to have drunk bottled water than persons with C. jejuni infection and, in general, were more likely to have eaten pâté (logistic regression analysis; Table 3). Retired persons who ate meat pies were more likely to be infected with C. coli than C. jejuni, as were Asians who had traveled abroad in the 2 weeks before illness. Case-patients with C. coli infection were, in general, less likely to be ill in the summer, and men who traveled abroad in the 2 weeks before illness were more likely to be infected with C. jejuni infection.


To our knowledge, this population-based sentinel surveillance system for campylobacter infection is unique because we have successfully linked detailed epidemiologic exposure information with detailed microbiologic strain characterization for a large sentinel population. Campylobacters are widely distributed in the environment, and this genus is adapted to a wide range of ecologic niches throughout the food chain (22). Microbiologic data show that the prevalence of different campylobacter species and subtypes varies between different potential sources of infection, including different animal species, foods, and water (2327). Although C. coli infection accounts for a small proportion of laboratory-confirmed human campylobacter cases in England and Wales, the potential for prevention is substantial if the true population burden is much higher (3). Most case-control studies have so far sought to determine risk factors for sporadic infection with campylobacter and have not sought to differentiate between species (57). This distinction is important if C. coli and C. jejuni differ in their etiology or if the contribution of similar risk factors differs between the two species. If exposures are aggregated for different pathogenic campylobacter species, the contribution of risk factors unique to or predominantly associated with C. coli will be masked by the predominance of C. jejuni (in the study population: C. jejuni: C. coli approximately 10:1). This source of bias can be overcome by comparing the exposure characteristics of cases with C. coli infection with those of cases with C. jejuni infection. The data for cases with C. jejuni infection are then used to contrast with, rather than dilute, any observations for C. coli infection. Therefore, in generating hypotheses for infection, we identified potential species differences by adopting case-case analysis.

Hypothesis: Bottled Water

Case-patients with C. coli infection were more likely to report bottled water consumption than were those with C. jejuni infection. This observation is biologically plausible. Raw water can be contaminated with C. coli (28,29) and, while European legislation governing the marketing of natural mineral water makes it a condition that it be free from parasites and pathogenic organisms (30), testing for campylobacters is rarely undertaken (31). As the bottled water industry is large ($35 billion a year worldwide [32]) and expanding rapidly (consumption in the United States, which was 5 billion gallons in 2000, is predicted to increase to 7.3 billion gallons in 2005 [32]), an accurate assessment of the risk associated with these products is required. Our hypothesis-generating questionnaire did not distinguish between types of bottled water (e.g., spring or mineral, carbonated, or still), but these issues merit further investigation by case-control study.

Hypothesis: Pâté

The finding that having eaten pâté was more likely to be reported by case-patients with C. coli infection than those with C. jejuni infection is also biologically plausible. Pork is often the main constituent of pâté, and C. coli is found in pigs (33). In a recent study of the occurrence of campylobacters in 400 freshly eviscerated porcine liver samples, 6% were infected with Campylobacter spp; most (67%) were C. coli (34). Pâté is a perishable comminuted meat product containing nitrite, and possibly nitrate, ascorbate, or both (35). While the use of such preservatives might deter the growth of spoilage microorganisms (assuming adequate storage conditions are maintained), vegetative pathogens might not be destroyed; therefore, the ultimate critical control point during production is likely to be effective heat treatment.

Hypothesis: Meat Pies

The fact that retired people with C. coli infection were more likely to report having eaten meat pies is interesting. The types of meat in the pie fillings are not known, but the finding might point to the use of cheaper cuts of meat in these products.

Hypothesis: Foreign Travel

Persons from a South Asian ethnic background who had traveled abroad in the 2 weeks before onset of symptoms were more likely to have acquired a C. coli infection, but the reverse was true for men. This finding probably reflects the fact that travel abroad is simply a marker for activities or behavior while abroad, and a further study of the “travel cohort,” generated through the surveillance scheme, might provide a better indication of where the risks lie.

Hypothesis: Seasonality

Campylobacter infection has marked seasonality, and case-patients infected with C. coli were less likely to be ill in the summer than those infected with C. jejuni. As data accumulate, generating season-specific hypotheses might be possible, which may have implications for the time period over which analytic studies are performed.

Sources of Bias

In interpreting the results from the sentinel surveillance system, likely sources of bias should be considered. Selection bias has been minimized by including all laboratory-confirmed cases of campylobacter infection identified by PHLS and National Health Service laboratories in the participating districts. Furthermore, both groups in the case-case comparison have been subjected to the same selection process, so selection bias should not influence our analysis.

The effect of time delays in reaching the patient, and hence recall bias for reported exposures, should be limited by close collaboration between the various participants in the scheme. While the time delay reported in this study introduces some recall bias, there is no reason to believe that recall is operating differently among patients infected with different species or among exposure groups, so that recall bias should not influence the case-case comparison.

Interpreting Case-Case Analyses

A detailed account of the pros and cons of case-case analysis is provided by McCarthy and Giesecke (16), but two important points influence the interpretation of this type of study. The first is that exposures that are a risk for infection for both comparison groups will not be identified or might be underestimated. By using patients with campylobacter infection, albeit with a different species, as “controls,” we may obscure an association with the infection of interest because the controls might share some of the risk exposures with the cases. Thus, exposures common to both infections are controlled for by the study design.

The second is that traditionally controls are selected to provide an estimate of the exposure prevalence that would be seen in the cases if there were no association between the exposure and disease. Since our controls have been differentially selected by factors that are related to certain exposures, they might not be representative of the exposure prevalence of the population group from which the cases originated. We cannot, therefore, use comparisons between our cases and controls to make statements about the magnitude or direction of population risk.


Our work has shown that important differences in exposures might exist for these two campylobacter species. This finding is not necessarily surprising. For example, nontyphoidal salmonellosis is well recognized to represent a large group of serotypes, each with its own distinctive epidemiology (36). Given this knowledge, conducting a case-control study with a case definition comprising Salmonella spp. is inconceivable. Why should the same not be true for Campylobacter spp.? The implications for analytic study design are that researchers should not aggregate different species, which may mask important species-specific risk factors. Thus, the comparison of two organisms thought to represent one disease with a common cause has provided new avenues for the epidemiologic investigation of human disease. Focused analytical studies, based on systematically generated hypotheses, determining etiologic fractions for the risk factors identified, will allow informed prevention strategies for human infection.



We are most grateful to H.R. Smith for his helpful comments on the manuscript. We thank the Campylobacter Sentinel Surveillance Scheme Steering Group, whose membership comprises J.M. Cowden, Scottish Centre for Infection and Environmental Health, Glasgow, United Kingdom (UK); J.A. Frost, Public Health Laboratory Service (PHLS) Laboratory of Enteric Pathogens, London, UK; I.A. Gillespie, PHLS Communicable Disease Surveillance Centre, London, UK; J. Millward, Birmingham City Council, Birmingham, UK; K.R. Neal, University of Nottingham, Nottingham, UK; S.J. O’Brien, PHLS Communicable Disease Surveillance Centre, London, UK; M.J. Painter, Manchester Health Authority, Manchester, UK; Q. Syed, Communicable Disease Surveillance Centre North West, Chester, UK; A.V. Swan, PHLS Statistics Unit, London, UK; and D. Tompkins, Leeds Public Health Laboratory, Leeds, UK.



  1. Friedman  CR, Neimann  J, Wegener  HC, Tauxe  R. Epidemiology of Campylobacter jejuni infection in the United States and other industrialized nations. In: Nachamkin I, Blaser MJ, editors. Campylobacter. Washington: ASM Press, 2001.
  2. Wheeler  JG, Sethi  D, Cowden  JM, Wall  PG, Rodrigues  LC, Tompkins  DS, Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. BMJ. 1999;318:104650.PubMedGoogle Scholar
  3. Food Standards Agency. Report of the study of infectious intestinal disease in England. London: The Stationery Office; 2000.
  4. Hahn  AF. Guillain-Barre syndrome. Lancet. 1998;352:63541. DOIPubMedGoogle Scholar
  5. Adak  GK, Cowden  JM, Nicholas  S, Evans  HS. The Public Health Laboratory Service national case-control study of primary indigenous sporadic cases of campylobacter infection. Epidemiol Infect. 1995;115:1522. DOIPubMedGoogle Scholar
  6. Kapperud  G, Skjerve  E, Bean  NH, Ostroff  SM, Lassen  J. Risk factors for sporadic Campylobacter infections: results of a case-control study in southeastern Norway. J Clin Microbiol. 1992;30:311721.PubMedGoogle Scholar
  7. Eberhart-Phillips  J, Walker  N, Garrett  N, Bell  D, Sinclair  D, Rainger  W, Campylobacteriosis in New Zealand: results of a case-control study. J Epidemiol Community Health. 1997;51:68691. DOIPubMedGoogle Scholar
  8. Neal  KR, Slack  RC. Diabetes mellitus, anti-secretory drugs and other risk factors for campylobacter gastro-enteritis in adults: a case-control study. Epidemiol Infect. 1997;119:30711. DOIPubMedGoogle Scholar
  9. Friedman  C, Reddy  S, Samuel  M, Marcus  R, Bender  J, Desai  S, ; EIP Working Group. Risk factors for sporadic campylobacter infections in the United States: a case-control study on FoodNet sites. Proceedings of the 2nd International Conference on Emerging Infectious Diseases; 2000 July 16–19; Atlanta, GA. Available from: URL: Accessed 20 September 2001.
  10. Rodrigues  LC, Cowden  JM, Wheeler  JG, Sethi  D, Wall  PG, Cumberland  P, The study of infectious intestinal disease in England: risk factors for cases of infectious intestinal disease with Campylobacter jejuni infection. Epidemiol Infect. 2001;127:18593. DOIPubMedGoogle Scholar
  11. Effler  P, Ieong  MC, Kimura  A, Nakata  M, Burr  R, Cremer  E, Sporadic Campylobacter jejuni infections in Hawaii: associations with prior antibiotic use and commercially prepared chicken. J Infect Dis. 2001;183:11525. DOIPubMedGoogle Scholar
  12. Nadeau  E, Messier  S, Quessy  S. Prevalence and comparison of genetic profiles of Campylobacter strains isolated from poultry and sporadic cases of campylobacteriosis in humans. J Food Prot. 2002;65:738.PubMedGoogle Scholar
  13. Vellinga  A, Van Loock  F. The dioxin crisis as experiment to determine poultry-related campylobacter enteritis. Emerg Infect Dis. 2002;8:1922.PubMedGoogle Scholar
  14. Advisory Committee on the Microbiological Safety of Food. Interim report on Campylobacter. London: Her Majesty’s Stationery Office; 1993.
  15. Anon.  Sentinel surveillance of campylobacter in England and Wales. Commun Dis Rep CDR Wkly 2000;10:169,172.
  16. McCarthy  N, Giesecke  J. Case-case comparisons to study causation of common infectious diseases. Int J Epidemiol. 1999;28:7648. DOIPubMedGoogle Scholar
  17. Bolton  FJ, Wareing  DR, Skirrow  MB, Hutchinson  DN. Identification and biotyping of campylobacters. In: Board GR, Jones D, Skinner FA, editors. Identification methods in applied and environmental microbiology. Oxford: Blackwell Scientific Publications, 1992:151–61.
  18. Frost  JA, Oza  AN, Thwaites  RT, Rowe  B. Serotyping scheme for Campylobacter jejuni and Campylobacter coli based on direct agglutination of heat-stable antigens. J Clin Microbiol. 1998;36:3359.PubMedGoogle Scholar
  19. Frost  JA, Kramer  J, Gillanders  SA. Phage typing of C. jejuni and C. coli. Epidemiol Infect. 1999;123:4755. DOIPubMedGoogle Scholar
  20. Thwaites  RT, Frost  JA. Drug resistance in Campylobacter jejuni, C. coli, and C. lari isolated from humans in north west England and Wales, 1997. J Clin Pathol. 1999;52:8124. DOIPubMedGoogle Scholar
  21. Office of Population Censuses and Surveys. Standard occupational classification volume 3: social classification and coding methodology. London: Her Majesty’s Stationery Office; 1991.
  22. Altekruse  SF, Stern  NJ, Fields  PI, Swerdlow  DL. Campylobacter jejuni—an emerging foodborne pathogen. Emerg Infect Dis. 1999;5:2835.PubMedGoogle Scholar
  23. Thomas  C, Gibson  H, Hill  DJ, Mabey  M. Campylobacter epidemiology: an aquatic perspective. J Appl Microbiol Symposium Supplement. 1999;85:1685775.
  24. Bolton  FJ, Dawkins  HC, Hutchinson  DN. Biotypes and serotypes of thermophilic campylobacters isolated from cattle, sheep and pig offal and other red meats. J Hyg (Lond). 1985;95:16.PubMedGoogle Scholar
  25. Mawer  SL. Campylobacters in man and the environment in Hull and East Yorkshire. Epidemiol Infect. 1988;101:28794. DOIPubMedGoogle Scholar
  26. Uyttendaele  M, De Troy  P, Debevere  J. Incidence of Salmonella, Campylobacter jejuni, Campylobacter coli, and Listeria monocytogenes in poultry carcasses and different types of poultry products for sale on the Belgian retail market. J Food Prot. 1999;62:73540.PubMedGoogle Scholar
  27. Whelan  CD, Monaghan  P, Girdwood  RW, Fricker  CR. The significance of wild birds (Larus sp.) in the epidemiology of Campylobacter infections in humans. Epidemiol Infect. 1988;101:25967. DOIPubMedGoogle Scholar
  28. Bolton  FJ, Coates  D, Hutchinson  DN, Godfree  AF. A study of thermophilic campylobacters in a river system. J Appl Bacteriol. 1987;62:16776.PubMedGoogle Scholar
  29. Jones  DM, Abbott  JD, Painter  MJ, Sutcliffe  EM. A comparison of biotypes and serotypes of Campylobacter sp. isolated from patients with enteritis and from animal and environmental sources. J Infect. 1984;9:518. DOIPubMedGoogle Scholar
  30. Hunter  PR. The microbiology of bottled natural mineral waters. J Appl Bacteriol. 1993;74:34552.PubMedGoogle Scholar
  31. Anon.  Statutory Instrument 1999 No. 1540. Natural mineral water, spring water and bottled drinking water regulations. London: The Stationery Office; 1999.
  32. Bottled Water Web Team. Portal for the bottled water industry. Available from: URL: Accessed 20 September 2001
  33. Skirrow  MB. Epidemiology of Campylobacter enteritis. Int J Food Microbiol. 1991;12:916. DOIPubMedGoogle Scholar
  34. Moore  JE, Madden  RH. Occurrence of thermophilic Campylobacter spp. in porcine liver in Northern Ireland. J Food Prot. 1998;61:40913.PubMedGoogle Scholar
  35. Madden  RH. Extending the shelf-life of vacuum-packaged pork liver pâté. J Food Prot. 1989;52:8815.
  36. Old  DC, Threlfall  EJ. Salmonella. In: Collier L, Balows A, Sussman M, editors. Topley & Wilson's microbiology and microbial infections. New York: Oxford University Press, Inc.; 1998: 969–97.




Cite This Article

DOI: 10.3201/eid0809.010187

1The Campylobacter Sentinel Surveillance System Collaborators comprise public health, environmental health, and laboratory staff who serve the populations of the following health authorities in England and Wales: Birmingham, Bradford, Bro Taf, Bury and Rochdale, Dyfed Powys, East Kent, Enfield & Haringey, Herefordshire, Leeds, Leicestershire; Manchester, North Cumbria, North Essex, North West Lancashire; Nottingham, Salford and Trafford, South and West Devon (part), South Lancashire, Southampton and South West Hampshire, Stockport, West Pennine, and Wigan and Bolton with the PHLS Laboratory of Enteric Pathogens, the PHLS Statistic Unit and the PHLS Communicable Disease Surveillance Centre.

Table of Contents – Volume 8, Number 9—September 2002

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Sarah J. O’Brien, Gastrointestinal Diseases Division, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London, United Kingdom NW9 5EQ; fax: 44 208 200 7868;

Send To

10000 character(s) remaining.


Page created: July 16, 2010
Page updated: July 16, 2010
Page reviewed: July 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.